Article Details

Short Interest in Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Declines By 22.5%

Retrieved on: 2021-03-06 08:48:45

Tags for this article:

Click the tags to see associated articles and topics

Short Interest in Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Declines By 22.5%. View article details on hiswai:

Excerpt

BlackRock Inc. now owns 405,918 shares of the company's stock worth $1,339,000 after buying an additional 18,793 shares in the last quarter. 25.99% ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up